Page last updated: 2024-08-16

technetium tc 99m sestamibi and Myositis Ossificans

technetium tc 99m sestamibi has been researched along with Myositis Ossificans in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jerushalmi, J; Khoury, J; Loberant, N1
Cermik, TF; Demiral, H; Erkmen, N; Gümüşer, FG; Gürbüz, H; Pekindil, G; Sarikaya, A1
Gross, K; Hackett, MT; Pulmano, C; Shih, WJ; Stipp, V1

Other Studies

3 other study(ies) available for technetium tc 99m sestamibi and Myositis Ossificans

ArticleYear
Tc-99m MIBI/Tc-99m MDP mismatch: a useful scintigraphic finding in differentiating myositis ossificans from malignant tumor of soft tissue.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:9

    Topics: Child; Humans; Intellectual Disability; Male; Muscles; Myositis Ossificans; Neoplasm Metastasis; Radionuclide Imaging; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

2006
Tc-99m MIBI accumulation in myositis ossificans.
    Clinical nuclear medicine, 1998, Volume: 23, Issue:11

    Topics: Humans; Knee; Male; Middle Aged; Myositis Ossificans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

1998
Myositis ossificans demonstrated by positive gallium-67 and technetium-99m-HMDP bone imaging but negative technetium-99m-MIBI imaging.
    Journal of nuclear medicine technology, 1999, Volume: 27, Issue:1

    Topics: Aged; Bone and Bones; Citrates; Gallium; Gallium Radioisotopes; Humans; Male; Myositis Ossificans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thigh

1999